The latest immunotherapy news and developments
Adjuvant nivolumab is superior to standard of care ipilimumab in patients with surgically resected stage…
Researchers at Fred Hutchinson Cancer Research Center showed about 70 percent of patients with the most common…
Cancer patients’ grey hair unexpectedly turned youthfully dark while taking novel drugs, and it has…
An international research team led by Université de Montréal medical professor Christopher Rudd, director of…
Whether a melanoma patient will better respond to a single immunotherapy drug or two in…
Combination therapy with two immunotherapy drugs produces an unprecedented doubling of response rates from 20…
A personal cancer treatment vaccine that targets distinctive “neoantigens” on tumour cells has been shown…
After radiation treatment, dying cancer cells spit out mutated proteins into the body. Scientists now…
The immunotherapy nivolumab is kinder than chemotherapy for people with advanced head and neck cancer…
In an expanded, three-year clinical trial of 86 patients with colorectal and 11 other kinds…